This article explains when common GLP-1 side effects may be manageable, when they should be discussed with a doctor, and why dose strategy, hydration, nutrition, bowel function, medication interactions, and follow-up care matter
Tirzepatide's added GIP activity is thought to drive the larger effect on top of the shared GLP-1 pathway though weight loss is only one part of the picture, and semaglutide still has the longer cardiovascular-outcomes track record (more on that below)
Answer 6 questions and see what patients with similar goals are running: which peptides they use, typical dosing, injection schedule, reconstitution steps, cycle length, and when they pause
How to Use for Best Results: Lather: Wet the soap and create a rich lather in your hands
Researcher Inquiries Retatrutide (LY3437943) is a synthetic 39-amino acid peptide engineered as a triple receptor agonist targeting the GIP, GLP-1, and glucagon (GCG) receptors
Sermorelin is a synthetic 29-amino-acid peptide that mimics growth hormone-releasing hormone (GHRH), the signal the hypothalamus sends to the pituitary gland to trigger growth hormone release
